TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Genfit
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GENFIT reported its semi-annual liquidity contract statement with Crédit Industriel et Commercial for H2 2025. During the period, 1.33 million shares were purchased for €4.99 million and 1.52 million shares were sold for €5.71 million across 5,161 total transactions. The company continues developing therapies for rare liver diseases, with Iqirvo® (elafibranor) now commercialized in multiple countries following regulatory approvals.

Insights
IPSEY   neutral

Ipsen is mentioned as a major shareholder (8% stake since 2021) and as the commercializing partner for Iqirvo®. The article provides no new information about Ipsen's performance or commercial progress with the drug, making sentiment neutral.